MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective

Schizophrenia as a Disorder of Molecular Pathways

(2015) Szatmár Horváth et al.   BIOLOGICAL PSYCHIATRY

Abnormal Cortical Growth in Schizophrenia Targets Normative Modules of Synchronized Development

(2014) Aaron F. Alexander-Bloch et al.   BIOLOGICAL PSYCHIATRY

The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment

(2014) Felice Iasevoli et al.   Current Neuropharmacology

MicroRNAs in Neuronal Communication

(2014) Guilherme Shigueto Vilar Higa et al.   MOLECULAR NEUROBIOLOGY

MicroRNA Expression Signatures Determine Prognosis and Survival in Glioblastoma Multiforme—a Systematic Overview

(2014) Michael Henriksen et al.   MOLECULAR NEUROBIOLOGY

Transcriptome-wide Discovery of microRNA Binding Sites in Human Brain

(2014) Ryan L. Boudreau et al.   NEURON

Identification of Developmentally Regulated PCP-Responsive Non-Coding RNA, prt6, in the Rat Thalamus

(2014) Hironao Takebayashi et al.   PLoS One

Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells

(2014) Matthew J. Hill et al.   SCHIZOPHRENIA RESEARCH

Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders

(2014) Elisabetta Maffioletti et al.   Frontiers in Cellular Neuroscience

MicroRNAs - A New Generation Molecular Targets for Treating Cellular Diseases

(2014) Ramasamy Paulmurugan   Theranostics

Can MicroRNAs Improve the Management of Lung Cancer Patients? A Clinician's Perspective

(2014) Amanda Tufman et al.   Theranostics

Micro-RNAs as Potential New Molecular Biomarkers in Oncology: Have They Reached Relevance for the Clinical Imaging Sciences?

(2014) Frank Berger et al.   Theranostics

Multifunctional Iron Oxide Nanoparticles for Diagnostics, Therapy and Macromolecule Delivery

(2014) Swee Kuan Yen et al.   Theranostics

MicroRNA-206: a Promising Theranostic Marker

(2014) Jan Novák et al.   Theranostics

Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors

(2013) Ranjan Dutta et al.   ANNALS OF NEUROLOGY

Biomarkers in schizophrenia

(2013) Gabriel Vargas   Biomarkers in Medicine

The role of Homer 1a in increasing locomotor activity and non-selective attention, and impairing learning and memory abilities

(2013) Lei Yang et al.   BRAIN RESEARCH

Derepression of a Neuronal Inhibitor due to miRNA Dysregulation in a Schizophrenia-Related Microdeletion

(2013) Bin Xu et al.   CELL

Intracellular pathways of antipsychotic combined therapies: Implication for psychiatric disorders treatment

(2013) Andrea de Bartolomeis et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Imaging brain gene expression profiles by antipsychotics: Region-specific action of amisulpride on postsynaptic density transcripts compared to haloperidol

(2013) Andrea de Bartolomeis et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex

(2013) Ilaria Guella et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Decreased levels of d-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia

(2013) Francesco Errico et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches

(2013) Andrea de Bartolomeis et al.   MOLECULAR NEUROBIOLOGY

The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia

(2013) T A Lett et al.   MOLECULAR PSYCHIATRY

Differential Expression of Exosomal microRNAs in Prefrontal Cortices of Schizophrenia and Bipolar Disorder Patients

(2013) Meredith G. Banigan et al.   PLoS One

Regulation of Dopamine D1 Receptor Dynamics within the Postsynaptic Density of Hippocampal Glutamate Synapses

(2013) Laurent Ladepeche et al.   PLoS One

Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: Role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis

(2013) Andrea de Bartolomeis et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine

(2013) Danielle M. Santarelli et al.   PSYCHOPHARMACOLOGY

Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia

(2013) Meredith A. Reid et al.   SCHIZOPHRENIA RESEARCH

Effects of antipsychotic drugs on the expression of synaptic proteins and dendritic outgrowth in hippocampal neuronal cultures

(2013) Sung Woo Park et al.   SYNAPSE

Rethinking schizophrenia in the context of normal neurodevelopment

(2013) Vibeke S. Catts et al.   Frontiers in Cellular Neuroscience

Potential Impact of miR-137 and Its Targets in Schizophrenia

(2013) Carrie Wright et al.   Frontiers in Genetics

New insights on the role of free d-aspartate in the mammalian brain

(2012) Francesco Errico et al.   AMINO ACIDS

Targeting glutamate system for novel antipsychotic approaches: Relevance for residual psychotic symptoms and treatment resistant schizophrenia

(2012) Andrea de Bartolomeis et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs

(2012) Daniela Tardito et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Calcyon Forms a Novel Ternary Complex with Dopamine D1Receptor through PSD-95 Protein and Plays a Role in Dopamine Receptor Internalization

(2012) Chang Man Ha et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

PSD-95 expression controls l-DOPA dyskinesia through dopamine D1 receptor trafficking

(2012) Gregory Porras et al.   JOURNAL OF CLINICAL INVESTIGATION

Evaluation of Six SNPs of MicroRNA Machinery Genes and Risk of Schizophrenia

(2012) Yi Zhou et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

In Vivo MicroRNA Detection and Quantitation in Cerebrospinal Fluid

(2012) Juan A. Gallego et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Primary microRNA precursor transcripts are localized at post-synaptic densities in adult mouse forebrain

(2012) Giovanni Lugli et al.   JOURNAL OF NEUROCHEMISTRY

Age-Dependent MicroRNA Control of Synaptic Plasticity in 22q11 Deletion Syndrome and Schizophrenia

(2012) L. R. Earls et al.   JOURNAL OF NEUROSCIENCE

A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain implicates susceptibility genes for schizophrenia

(2012) Mie A Rizig et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Calcium-Dependent Networks in Dopamine–Glutamate Interaction: The Role of Postsynaptic Scaffolding Proteins

(2012) Andrea de Bartolomeis et al.   MOLECULAR NEUROBIOLOGY

Polymer Nanoparticle-Mediated Delivery of MicroRNA Inhibition and Alternative Splicing

(2012) Christopher J. Cheng et al.   MOLECULAR PHARMACEUTICS

Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia

(2012) M J Green et al.   MOLECULAR PSYCHIATRY

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

(2012) S Miyamoto et al.   MOLECULAR PSYCHIATRY

Scaffolding Proteins of the Post-synaptic Density Contribute to Synaptic Plasticity by Regulating Receptor Localization and Distribution: Relevance for Neuropsychiatric Diseases

(2012) Felice Iasevoli et al.   NEUROCHEMICAL RESEARCH

Dopamine facilitates dendritic spine formation by cultured striatal medium spiny neurons through both D1 and D2 dopamine receptors

(2012) Caroline Fasano et al.   NEUROPHARMACOLOGY

Impact of a microRNA MIR137 Susceptibility Variant on Brain Function in People at High Genetic Risk of Schizophrenia or Bipolar Disorder

(2012) Heather C Whalley et al.   NEUROPSYCHOPHARMACOLOGY

Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137

(2012) E. Cummings et al.   NEUROSCIENCE LETTERS

Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain

(2012) Katrina Weston-Green et al.   PLoS One

MicroRNA 142-3p Mediates Post-Transcriptional Regulation of D1 Dopamine Receptor Expression

(2012) Krishna E. Tobón et al.   PLoS One

miRNA Regulons Associated with Synaptic Function

(2012) Maria Paschou et al.   PLoS One

MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function

(2012) B. H. Miller et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

MicroRNA-223 is neuroprotective by targeting glutamate receptors

(2012) M. M. Harraz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins

(2012) A. de Bartolomeis et al.   PSYCHOPHARMACOLOGY

Expression of NPAS3 in the Human Cortex and Evidence of Its Posttranscriptional Regulation by miR-17 During Development, With Implications for Schizophrenia

(2012) Jenny Wong et al.   SCHIZOPHRENIA BULLETIN

MicroRNA Conjugated Gold Nanoparticles and Cell Transfection

(2011) Elizabeth Crew et al.   ANALYTICAL CHEMISTRY

A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA

(2011) Do Won Hwang et al.   BIOMATERIALS

Regulation of PI3K/Akt signaling by N-desmethylclozapine through activation of δ-opioid receptor

(2011) Maria C. Olianas et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life

(2011) Teresa Marie du Bois et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The dopamine D2 receptor regulates Akt and GSK-3 via Dvl-3

(2011) Laurie P. Sutton et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Regulation of Akt and Wnt signaling by the group II metabotropic glutamate receptor antagonist LY341495 and agonist LY379268

(2011) Laurie P. Sutton et al.   JOURNAL OF NEUROCHEMISTRY

Deletion of Astroglial Dicer Causes Non-Cell-Autonomous Neuronal Dysfunction and Degeneration

(2011) J. Tao et al.   JOURNAL OF NEUROSCIENCE

Aberrant expression of serum miRNAs in schizophrenia

(2011) Wenting Shi et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Dopamine-Regulated MicroRNA MiR-181a Controls GluA2 Surface Expression in Hippocampal Neurons

(2011) R. Saba et al.   MOLECULAR AND CELLULAR BIOLOGY

Reversible Inhibition of PSD-95 mRNA Translation by miR-125a, FMRP Phosphorylation, and mGluR Signaling

(2011) Ravi S. Muddashetty et al.   MOLECULAR CELL

Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells

(2011) E Gardiner et al.   MOLECULAR PSYCHIATRY

De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia

(2011) G Kirov et al.   MOLECULAR PSYCHIATRY

Genome-wide association study identifies five new schizophrenia loci

(2011)   NATURE GENETICS

Silencing of microRNA families by seed-targeting tiny LNAs

(2011) Susanna Obad et al.   NATURE GENETICS

Exposure to novel environment is characterized by an interaction of D1/NMDA receptors underlined by phosphorylation of the NMDA and AMPA receptor subunits and activation of ERK1/2 signaling, leading to epigenetic changes and gene expression in rat hippocampus

(2011) Konstantinos Sarantis et al.   NEUROCHEMISTRY INTERNATIONAL

From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

(2011) Bita Moghaddam et al.   NEUROPSYCHOPHARMACOLOGY

Solid Lipid Nanoparticles Loaded with Anti-microRNA Oligonucleotides (AMOs) for Suppression of MicroRNA-21 Functions in Human Lung Cancer Cells

(2011) San-Jun Shi et al.   PHARMACEUTICAL RESEARCH

The Physiology, Signaling, and Pharmacology of Dopamine Receptors

(2011) J.-M. Beaulieu et al.   PHARMACOLOGICAL REVIEWS

Effects of Dopamine and Glutamate on Synaptic Plasticity: A Computational Modeling Approach for Drug Abuse as Comorbidity in Mood Disorders

(2011) Z. Qi et al.   PHARMACOPSYCHIATRY

MicroRNA Expression Aberration as Potential Peripheral Blood Biomarkers for Schizophrenia

(2011) Chi-Yu Lai et al.   PLoS One

MicroRNA regulation of homeostatic synaptic plasticity

(2011) J. E. Cohen et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Association of MouseDlg4(PSD-95) Gene Deletion and HumanDLG4Gene Variation With Phenotypes Relevant to Autism Spectrum Disorders and Williams' Syndrome

(2010) Michael Feyder et al.   AMERICAN JOURNAL OF PSYCHIATRY

Upregulation of Dicer and MicroRNA Expression in the Dorsolateral Prefrontal Cortex Brodmann Area 46 in Schizophrenia

(2010) Danielle M. Santarelli et al.   BIOLOGICAL PSYCHIATRY

Altered MicroRNA Expression Profiles in Postmortem Brain Samples from Individuals with Schizophrenia and Bipolar Disorder

(2010) Michael P. Moreau et al.   BIOLOGICAL PSYCHIATRY

Differential regulation of mature and precursor microRNA expression by NMDA and metabotropic glutamate receptor activation during LTP in the adult dentate gyrusin vivo

(2010) Karin Wibrand et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

d-Aspartic acid is a novel endogenous neurotransmitter

(2010) Salvatore D'Aniello et al.   FASEB JOURNAL

The road toward microRNA therapeutics

(2010) Anita G. Seto   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Therapeutic Advances in MicroRNA Targeting

(2010) Rusty L Montgomery et al.   JOURNAL OF CARDIOVASCULAR PHARMACOLOGY

MicroRNA-148/152 Impair Innate Response and Antigen Presentation of TLR-Triggered Dendritic Cells by Targeting CaMKII 

(2010) X. Liu et al.   JOURNAL OF IMMUNOLOGY

In Vivo Composition of NMDA Receptor Signaling Complexes Differs between Membrane Subdomains and Is Modulated by PSD-95 And PSD-93

(2010) I. Delint-Ramirez et al.   JOURNAL OF NEUROSCIENCE

Dysregulation of Presynaptic Calcium and Synaptic Plasticity in a Mouse Model of 22q11 Deletion Syndrome

(2010) L. R. Earls et al.   JOURNAL OF NEUROSCIENCE

MicroRNA Loss Enhances Learning and Memory in Mice

(2010) W. Konopka et al.   JOURNAL OF NEUROSCIENCE

Regulation of Opioid Tolerance by let-7 Family MicroRNA Targeting the   Opioid Receptor

(2010) Y. He et al.   JOURNAL OF NEUROSCIENCE

Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients

(2010) Ilja Spellmann et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first- and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes

(2010) Felice Iasevoli et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Striatal microRNA controls cocaine intake through CREB signalling

(2010) Jonathan A. Hollander et al.   NATURE

Regulation of Synaptic Structure and Function by FMRP-Associated MicroRNAs miR-125b and miR-132

(2010) Dieter Edbauer et al.   NEURON

Genetic and Functional Analysis of the DLG4 Gene Encoding the Post-Synaptic Density Protein 95 in Schizophrenia

(2010) Min-Chih Cheng et al.   PLoS One

Haloperidol induces higher Homer1a expression than risperidone, olanzapine and sulpiride in striatal sub-regions

(2010) Felice Iasevoli et al.   PSYCHIATRY RESEARCH

Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole

(2010) Felice Iasevoli et al.   PSYCHOPHARMACOLOGY

Gender-Specific Reduction of Estrogen-Sensitive Small RNA, miR-30b, in Subjects With Schizophrenia

(2010) Nikolaos Mellios et al.   SCHIZOPHRENIA BULLETIN

MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia

(2010) Yong Xu et al.   SCHIZOPHRENIA RESEARCH

MicroRNA miR-137 Regulates Neuronal Maturation by Targeting Ubiquitin Ligase Mind Bomb-1

(2010) Richard D. Smrt et al.   STEM CELLS

Dicerablation in oligodendrocytes provokes neuronal impairment in mice

(2009) Daesung Shin et al.   ANNALS OF NEUROLOGY

Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat

(2009) Claire E. McKibben et al.   BEHAVIOURAL BRAIN RESEARCH

Targeting Homer genes using adeno-associated viral vector: lessons learned from behavioural and neurochemical studies

(2009) Matthias Klugmann et al.   BEHAVIOURAL PHARMACOLOGY

Differential Allelic Expression of Dopamine D1 Receptor Gene (DRD1) Is Modulated by microRNA miR-504

(2009) Weihua Huang et al.   BIOLOGICAL PSYCHIATRY

PSD-95 regulates D1 dopamine receptor resensitization, but not receptor-mediated Gs-protein activation

(2009) Peihua Sun et al.   CELL RESEARCH

Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex

(2009) Maria Sol Kruse et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

PSD-95 Uncouples Dopamine-Glutamate Interaction in the D1/PSD-95/NMDA Receptor Complex

(2009) J. Zhang et al.   JOURNAL OF NEUROSCIENCE

Chronic infusion of PCP via osmotic mini-pumps: A new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance

(2009) Christian Spang Pedersen et al.   JOURNAL OF NEUROSCIENCE METHODS

microRNAs miR-124, let-7d and miR-181a regulate Cocaine-induced Plasticity

(2009) Vijay Chandrasekar et al.   MOLECULAR AND CELLULAR NEUROSCIENCE

A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis

(2009) Gabriele Siegel et al.   NATURE CELL BIOLOGY

miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche

(2009) Li-Chun Cheng et al.   NATURE NEUROSCIENCE

microRNAs in CNS Disorders

(2009) Jannet Kocerha et al.   NEUROMOLECULAR MEDICINE

Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: Involvement of ERK1/2 signaling

(2009) K. Sarantis et al.   NEUROSCIENCE

Behavioral sensitization to cocaine is associated with increased glutamate receptor trafficking to the postsynaptic density after extended withdrawal period

(2009) M.B. Ghasemzadeh et al.   NEUROSCIENCE

Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression

(2009) H. Kawashima et al.   NEUROSCIENCE

Antipsychotic drug actions on gene modulation and signaling mechanisms

(2009) Raffaella Molteni et al.   PHARMACOLOGY & THERAPEUTICS

Evidence for X-Chromosomal Schizophrenia Associated with microRNA Alterations

(2009) Jinong Feng et al.   PLoS One

MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction

(2009) J. Kocerha et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dopamine receptor subtypes contribution to Homer1a induction: Insights into antipsychotic molecular action

(2009) Felice Iasevoli et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene

(2009) Yanglong Zhu et al.   SCHIZOPHRENIA RESEARCH

Synapse- and Stimulus-Specific Local Translation During Long-Term Neuronal Plasticity

(2009) D. O. Wang et al.   SCIENCE

Neurotransmitters Drive Combinatorial Multistate Postsynaptic Density Networks

(2009) M. P. Coba et al.   Science Signaling

Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism

(2008) Zohreh Talebizadeh et al.   Autism Research

miR-142-3p restricts cAMP production in CD4+CD25− T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA

(2008) Bo Huang et al.   EMBO REPORTS

Dysregulation of miRNA 181b in the temporal cortex in schizophrenia

(2008) Natalie J. Beveridge et al.   HUMAN MOLECULAR GENETICS

Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain

(2008) Giovanni Lugli et al.   JOURNAL OF NEUROCHEMISTRY

D-Aspartate Prevents Corticostriatal Long-Term Depression and Attenuates Schizophrenia-Like Symptoms Induced by Amphetamine and MK-801

(2008) F. Errico et al.   JOURNAL OF NEUROSCIENCE

Conditional Loss of Dicer Disrupts Cellular and Tissue Morphogenesis in the Cortex and Hippocampus

(2008) T. H. Davis et al.   JOURNAL OF NEUROSCIENCE

LNA-mediated microRNA silencing in non-human primates

(2008) Joacim Elmén et al.   NATURE

Strong association of de novo copy number mutations with sporadic schizophrenia

(2008) Bin Xu et al.   NATURE GENETICS

Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model

(2008) Kimberly L Stark et al.   NATURE GENETICS

Evolutionary expansion and anatomical specialization of synapse proteome complexity

(2008) Richard D Emes et al.   NATURE NEUROSCIENCE

CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking

(2008) Sharon M Anderson et al.   NATURE NEUROSCIENCE

Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion

(2008) Jun Mukai et al.   NATURE NEUROSCIENCE

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

(2008) Witold Filipowicz et al.   NATURE REVIEWS GENETICS

Group I Metabotropic Glutamate Receptor-mediated Gene Expression in Striatal Neurons

(2008) Li-Min Mao et al.   NEUROCHEMICAL RESEARCH

Heterogeneous dysregulation of microRNAs across the autism spectrum

(2008) Kawther Abu-Elneel et al.   NEUROGENETICS

Protein–protein interactions as therapeutic targets in neuropsychopharmacology

(2008) Matthew T Reilly et al.   NEUROPSYCHOPHARMACOLOGY

Evidence for Selective microRNAs and Their Effectors as Common Long-Term Targets for the Actions of Mood Stabilizers

(2008) Rulun Zhou et al.   NEUROPSYCHOPHARMACOLOGY

Interaction between N-methyl-d-aspartic acid receptors and D1 dopamine receptors: An important mechanism for brain plasticity

(2008) L. Scott et al.   NEUROSCIENCE

Striatal D2/D3 Receptor Occupancy, Clinical Response and Side Effects with Amisulpride: An Iodine-123-Iodobenzamide SPET Study

(2008) E. Meisenzahl et al.   PHARMACOPSYCHIATRY

Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration

(2008) T. L. Cuellar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP

(2008) Gary A. Wayman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cocaine activates Homer1 immediate early gene transcription in the mesocorticolimbic circuit: Differential regulation by dopamine and glutamate signaling

(2008) M. Behnam Ghasemzadeh et al.   SYNAPSE